DK1515729T3 - Kvaterniserede ammoniumcyclodextrinforbindelser - Google Patents

Kvaterniserede ammoniumcyclodextrinforbindelser

Info

Publication number
DK1515729T3
DK1515729T3 DK03740232T DK03740232T DK1515729T3 DK 1515729 T3 DK1515729 T3 DK 1515729T3 DK 03740232 T DK03740232 T DK 03740232T DK 03740232 T DK03740232 T DK 03740232T DK 1515729 T3 DK1515729 T3 DK 1515729T3
Authority
DK
Denmark
Prior art keywords
compound
alkylene
group selected
cyclodextrin
quaternized ammonium
Prior art date
Application number
DK03740232T
Other languages
Danish (da)
English (en)
Inventor
Georg Ludwig Kis
Christian Schoch
Jozsef Szejtli
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1515729T3 publication Critical patent/DK1515729T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK03740232T 2002-06-13 2003-06-12 Kvaterniserede ammoniumcyclodextrinforbindelser DK1515729T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02013074 2002-06-13
EP02028554 2002-12-20
PCT/EP2003/006192 WO2003105867A1 (en) 2002-06-13 2003-06-12 Quaternised ammonium cyclodextrin compounds

Publications (1)

Publication Number Publication Date
DK1515729T3 true DK1515729T3 (da) 2008-06-16

Family

ID=29737927

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03740232T DK1515729T3 (da) 2002-06-13 2003-06-12 Kvaterniserede ammoniumcyclodextrinforbindelser

Country Status (15)

Country Link
US (4) US20050222085A1 (enExample)
EP (1) EP1515729B1 (enExample)
JP (2) JP4773721B2 (enExample)
CN (1) CN100589809C (enExample)
AT (1) ATE386532T1 (enExample)
AU (1) AU2003276957A1 (enExample)
BR (1) BR0311722A (enExample)
CA (1) CA2487332C (enExample)
CY (1) CY1108099T1 (enExample)
DE (1) DE60319221T2 (enExample)
DK (1) DK1515729T3 (enExample)
ES (1) ES2301807T3 (enExample)
PT (1) PT1515729E (enExample)
SI (1) SI1515729T1 (enExample)
WO (1) WO2003105867A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100678824B1 (ko) * 2005-02-04 2007-02-05 한미약품 주식회사 용해성이 증가된 무정형 타크로리무스 고체분산체 및 이를포함하는 약제학적 조성물
EP2522343A1 (en) 2006-03-28 2012-11-14 Javelin Pharmaceuticals, Inc. Formulations of Low Dose Diclofenac and Beta-Cyclodextrin
WO2008120249A1 (en) * 2007-03-30 2008-10-09 Sifi S.P.A. Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
CN101757621B (zh) * 2008-11-28 2012-07-04 天津金耀集团有限公司 一种眼部抗炎的环糊精包合药物组合物
US9642920B2 (en) * 2009-06-03 2017-05-09 Case Western Reserve University Therapeutic agent delivery system and method
CN102276761A (zh) * 2010-06-11 2011-12-14 南京理工大学 单取代铵基正电型-β-环糊精及其制备方法
GB201114459D0 (en) * 2011-08-22 2011-10-05 Isis Innovation Anti-bacterial compounds
CN103497275B (zh) * 2013-08-09 2015-12-23 华北电力大学（保定） 一种抗菌、抗病毒胍盐星形聚合物及其制备方法和应用
CZ307458B6 (cs) * 2014-11-25 2018-09-12 Spur A.S. Vícevrstvý kryt rány s aktivní vrstvou a způsob jeho výroby
EP3227379B1 (en) * 2014-12-02 2020-07-29 B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University Quaternized starches for use as anti-microbial agents
CN109487588B (zh) * 2018-11-19 2021-04-20 绍兴永通印花有限公司 一种印花用涤纶织物处理液及其使用方法
CN113056516B (zh) 2019-02-14 2022-05-13 赛克洛珀股份有限公司 带有电荷的环糊精聚合物材料以及其制造和使用方法
CN109836512A (zh) * 2019-03-04 2019-06-04 西南石油大学 一种新型β-CD双子表面活性剂为稠化剂的清洁压裂液
CN112386710A (zh) * 2020-12-09 2021-02-23 星拜(苏州)生物科技有限公司 一种利用包埋技术改善紫檀芪水溶性的方法
CN116987213B (zh) * 2022-04-26 2025-09-09 中国石油化工股份有限公司 一种具有表面活性剂功能的化合物、一种表面活性剂及其制备方法
KR20250161522A (ko) 2023-01-12 2025-11-17 사이클로퓨어, 인코포레이티드 중합체 시클로덱스트린 흡착제의 재생

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3453257A (en) * 1967-02-13 1969-07-01 Corn Products Co Cyclodextrin with cationic properties
JPS58210901A (ja) * 1982-06-01 1983-12-08 Kao Corp シクロデキストリン誘導体およびその製造方法
IT1229133B (it) * 1989-03-09 1991-07-22 Farmhispania Sali ammonici di policiclodestrine per l'impiego come agenti ipocolesterolemizzanti
KR927003645A (ko) * 1990-05-21 1992-12-18 후지다 히로미찌 씨클로덱스트린 유도체
JPH0481401A (ja) * 1990-07-24 1992-03-16 Toppan Printing Co Ltd シクロデキストリン誘導体
JPH0665307A (ja) * 1992-06-17 1994-03-08 Sankyo Co Ltd シクロデキストリン誘導体
AU3609795A (en) * 1994-10-10 1996-05-02 Novartis Ag Ophthalmic and aural compositions containing diclofenac potassium
JP3297969B2 (ja) * 1994-12-26 2002-07-02 ライオン株式会社 点眼剤
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
TW434023B (en) * 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
WO1999042111A1 (en) * 1998-02-23 1999-08-26 Cyclops, Ehf. High-energy cyclodextrin complexes

Also Published As

Publication number Publication date
CA2487332C (en) 2012-05-15
WO2003105867A1 (en) 2003-12-24
JP4773721B2 (ja) 2011-09-14
CY1108099T1 (el) 2014-02-12
US20130137657A1 (en) 2013-05-30
AU2003276957A1 (en) 2003-12-31
JP2011006448A (ja) 2011-01-13
PT1515729E (pt) 2008-05-30
ATE386532T1 (de) 2008-03-15
EP1515729B1 (en) 2008-02-20
CA2487332A1 (en) 2003-12-24
EP1515729A1 (en) 2005-03-23
US20120004158A1 (en) 2012-01-05
CN100589809C (zh) 2010-02-17
BR0311722A (pt) 2005-03-01
CN1658888A (zh) 2005-08-24
ES2301807T3 (es) 2008-07-01
US20090110734A1 (en) 2009-04-30
US20050222085A1 (en) 2005-10-06
DE60319221D1 (de) 2008-04-03
DE60319221T2 (de) 2009-03-05
SI1515729T1 (sl) 2008-08-31
JP2005529175A (ja) 2005-09-29

Similar Documents

Publication Publication Date Title
ATE386532T1 (de) Quaternisierte ammoniumcyclodextrinverbindungen
RU2213732C2 (ru) Гетероциклические производные и фармацевтическая композиция
RU2225404C2 (ru) ПРОИЗВОДНЫЕ ПИПЕРАЗИНА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ ИНГИБИРУЮЩЕЙ АКТИВНОСТЬЮ В ОТНОШЕНИИ ФАКТОРА Хa
Jeon et al. Effect of antimicrobial activity by chitosan oligosaccharide N-conjugated with asparagine
NO20021399L (no) Kazolinderivater og deres anvendelse som farmasöyter
WO2011072853A3 (en) Conditioning composition for hair
EP1634874A4 (en) imidazolidine
MX2024008480A (es) Compuesto heterociclico que contiene nitrogeno que tiene un efecto de activacion del factor 2 relacionado con el factor nuclear eritroide 2 (nrf2).
DE602005009924D1 (en) Synthetische multiple quaternäre ammoniumsalze
MD1788G2 (ro) Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase
DE60239000D1 (de) Carbazuckeraminderivate und mittel gegen störungenff enthalten
BRPI0407386A (pt) Derivados de álcool de amino, composições farmacêuticas contendo os mesmos e uso destes
BR9813779A (pt) Novos derivados do taxano
EP1027880A3 (de) Verwendung von quaternären Ammoniumverbindungen als Antitranspirantien
DE602005018100D1 (de) Zu lipidmembranen in archeabakterien analoge verbindungen und liposomale zusammensetzungen mit diesen verbindungen
AR012883A1 (es) Compuestos derivados de ciclobutilamina sustituida, composicion farmaceutica y agente antibacteriano.
WO2005016240A3 (en) Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same
NO975402L (no) Nye benzopyran forbindelser, fremgangsmÕte ved fremstilling av dem og farmas÷ytiske sammensetninger som inneholder dem
BR9815081A (pt) Compostos tricìclicos, um processo para a sua preparação e composições farmacêuticas contendo-os
KR960010739A (ko) 암모늄염을 함유하는 예비 중합체 및 이의 제조방법
SE430340B (sv) Forfarande for framstellning av nya nitrosokarbamidderivat
RU2220151C2 (ru) Стероидные производные, способы их получения, фармацевтическая композиция, способ лечения, способ подавления роста микробов
NO20055142L (no) Diarylmetylidenpiperidinderivater, fremstillinger og anvendelser derav
EP1827452A4 (en) 2-METHYLENE-19,21-DINOR-1alpha-HYDROXY-BISHOMOPREGNACALCIFEROL
WO2002024711A1 (en) Novel thiazole bicyclic compounds